Health Care/Hospital

Ultimate Japanese Anti-Aging Technology Comes To Hong Kong - SAISEICO Launches Nobel Prize Winning Japanese Exosome Skincare at Vegas 360 Spas.

HONG KONG, March 20, 2024 /PRNewswire/ -- Japanese Skincare Technology brand SAISEICO will be unveiling its trailblazing new EXCELLENE line of products at a special event in partnership with Vegas 360 spas who will be the first to stock this game changing skincare treatment line at its 18 luxury ...

2024-03-20 18:08 1332

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

BEIJING, March 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resu...

2024-03-20 17:30 1750

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

LAKE FOREST, Calif., March 20, 2024 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more than three million ICLs have bee...

2024-03-20 16:22 1615

AXA upgrades "SmartTraveller Plus"

Market-leading overseas virtual medical consultation service Providing worry-free travel experience for our customers HONG KONG, March 20, 2024 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the upgrade of "SmartTraveller Plus'', with newly-added benefits such as virtual medical c...

2024-03-20 16:02 1543

BGI Group Celebrates 20th Anniversary of Partnerships in Healthcare and Genomics in Thailand

BANGKOK, March 20, 2024 /PRNewswire/ -- This year marks the twentieth anniversary of BGI Group's close relationship with the Kingdom ofThailand. Initially both parties were brought together through an international humanitarian rescue effort during the Indian Ocean tsunami where BGI worked with ...

2024-03-20 12:39 1646

320 World Oral Health Day

Oral health is closely related to our well-being Experts call for " A HAPPY MOUTH IS…A HAPPY BODY" HONG KONG, March 20, 2024 /PRNewswire/ -- According to the latest Global Oral Health Status Report published by the World Health Organization inNovember 2022 , the prevalence of oral diseases is ra...

2024-03-20 12:00 440

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies

Proceeds to Support Advancement of Engrail's Pipeline for Neuropsychiatric and Neurodevelopmental Disorders  SAN DIEGO, March 20, 2024 /PRNewswire/ -- Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to impro...

2024-03-20 11:00 1429

Docquity enables Italian biopharmaceutical company Menarini to double HCP reach and engagement in Malaysia

* A Docquity client since 2021, Menarini Malaysia further engaged the platform to raise awareness among target HCPs on multimodal approaches to post-surgery pain management and recovery * Docquity's Awareness to Advocacy (A2A) Program, backed by its in-depth HCP network insights, droveMenarini...

2024-03-20 10:00 1406

Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients

SHANGHAI, March 20, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Singapore Health Sciences ...

2024-03-20 09:16 1344

FDI World Dental Federation releases powerful video message unifying voices in celebration of World Oral Health Day

In celebration of World Oral Health Day, FDI World Dental Federation debuts an impactful video message uniting voices from diverse sectors, advocating for collective efforts to improve oral health worldwide. GENEVA, March 20, 2024 /PRNewswire/ -- "A Happy Mouth is a Happy Body," says FDI World D...

2024-03-20 09:00 1123

Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101 in Renowned Oncology Journal Cancer Research

SHANGHAI and HONG KONG, March 20, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in he...

2024-03-20 08:30 1435

China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

HANGZHOU, China, March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...

2024-03-20 04:05 1618

Datasea Enters into Manufacturing Agreement to Accelerate Production and Deployment of its Hi-Tech Intelligent Acoustic Products

BEIJING, March 19, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada, dedicated to innovative business in acoustic high tech and 5G-Artificial Intelligence multimodal communication technology inthe United States and C...

2024-03-19 22:00 1075

SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential

SHANGHAI, March 19, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire industry chain, presented the clinical study data of the 9MW2821 for patients with cervical cancer as focused plenary oral presentation at the Society of Gynecologic Oncology ...

2024-03-19 22:00 1114

Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate

* A large Phase 3 trial will evaluate whether the M72/AS01E vaccine candidate can protect adolescents and adults from pulmonary tuberculosis * Clinical trial site at University of the Witwatersrand, Johannesburg, South Africa, is first of up to 60 sites in seven countries * The M72/AS01E vac...

2024-03-19 21:02 1292

Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure

ST. GALLEN, SWITZERLAND, March 19, 2024 /PRNewswire/ -- CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron deficiency anemia in adult and pediatric patients one year of age and older when oral iron preparations ...

2024-03-19 19:09 1942

Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound Technology Agreement at ECR 2024

The collaboration aims to improve ultrasound contrast agent utilization and image resolution, streamline workflow, and enhance clinical benefits for users and patients. MILAN, March 19, 2024 /PRNewswire/ -- Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracc...

2024-03-19 18:00 1557

LifeSpan Vision Ventures Invests in SENISCA

NORWALK, Conn., March 19, 2024 /PRNewswire/ -- LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced an investment in SENISCA, an RNA therapeutics spinout from the University of Exeter. The company has developed proprietary technology that har...

2024-03-19 17:00 1243

Leading Indonesian Fintech JULO Pioneers Healthcare Financing for Any Hospital, Any Dentist, Any Clinic in a Few Clicks

JAKARTA, Indonesia, March 19, 2024 /PRNewswire/ -- Continuing its commitment to financial inclusion inIndonesia, JULO has launched a distinctive nationwide healthcare financing feature. JULO Health is now available to finance Indonesians' healthcare needs across any of t...

2024-03-19 16:49 1369

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of genera...

2024-03-19 12:01 2058
1 ... 3456789 ... 802

Week's Top Stories